Cellares
Cellares makes cell therapies for drug developers using automated manufacturing systems. It calls itself an Integrated Development and Manufacturing Organization (IDMO): it runs its Cell Shuttle manufacturing platform and Cell Q quality-control workcell in its own Smart Factories and offers development, clinical and commercial production as a service. It has sites in South San Francisco and Bridgewater, New Jersey, with facilities planned in the Netherlands and Japan.
Health & biotechAutomated cell therapy manufacturing (contract development and manufacturing)South San Francisco, United States
FoundersSince 2019
- Fabian GerlinghausCEO
- Omar KurdiPresident
- Alex Pesch
- Total raised
- $682M
- Last round · Jun 2026
- Series D (extension)
- Founded
- 2019
Funding rounds
Team
- Fabian GerlinghausCo-Founder and CEO
- Omar KurdiCo-Founder and President
- Alex PeschCo-founder
- Ossama EissaChief Operating Officer
- Ali SoleymannezhadChief Commercial Officer



